Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients

Figure 2

Dot-plots of serum levels of nucleosomes, alkaline phosphatase (AP), alpha fetoprotein (AFP) and gamma-glutamyl-transferase (GGT) with respective medians of patients with response to therapy () and those with no response to therapy () for all time points during the first day after TACE ( indicate significant differences).

Back to article page